We are live on ! Find out more
VRTX icon

Vertex Pharmaceuticals
VRTX

376 hedge funds and large institutions have $17.1B invested in Vertex Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 376 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $419M | Put options by funds: $287M

Holders
376
Holders Change
+376
Holders Change %
–
% of All Funds
12.27%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
376
Increased
–
Reduced
–
Closed
–
Calls
$419M
Puts
$287M
Net Calls
+$131M
Net Calls Change
+$131M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
T
101
TOBAM
France
$15.1M +$13.9M +188,444 New
SG Americas Securities
102
SG Americas Securities
New York
$15M +$13.9M +188,289 New
MLICM
103
Metropolitan Life Insurance Company (MetLife)
New York
$15M +$13.8M +187,467 New
VanEck Associates
104
VanEck Associates
New York
$14.4M +$13.2M +179,806 New
Charles Schwab
105
Charles Schwab
California
$14.3M +$13.1M +177,391 New
ASRS
106
Arizona State Retirement System
Arizona
$14.1M +$13M +176,528 New
PPA
107
Parametric Portfolio Associates
Washington
$13.8M +$12.7M +172,827 New
SI
108
Scout Investments
Missouri
$13.4M +$12.3M +167,594 New
Axa
109
Axa
France
$13.3M +$12.2M +166,097 New
SCM
110
Suffolk Capital Management
New York
$13.2M +$12.1M +164,770 New
BNP Paribas Financial Markets
111
BNP Paribas Financial Markets
France
$12.9M +$11.9M +161,921 New
DekaBank Deutsche Girozentrale
112
DekaBank Deutsche Girozentrale
Germany
$12.2M +$11.2M +151,647 New
First Manhattan
113
First Manhattan
New York
$12.1M +$11.2M +151,412 New
Dimensional Fund Advisors
114
Dimensional Fund Advisors
Texas
$11.7M +$10.8M +146,688 New
Royal Bank of Canada
115
Royal Bank of Canada
Ontario, Canada
$11.2M +$10.3M +139,800 New
TRSOTSOK
116
Teachers Retirement System of the State of Kentucky
Kentucky
$11.1M +$10.2M +138,459 New
PA
117
Profund Advisors
Maryland
$10.7M +$9.9M +134,479 New
MOACM
118
Mutual of America Capital Management
New York
$10.6M +$9.74M +132,221 New
ACI
119
AMP Capital Investors
Australia
$10.5M +$9.64M +130,883 New
BlackRock
120
BlackRock
New York
$10.5M +$9.64M +130,858 New
ERSOT
121
Employees Retirement System of Texas
Texas
$9.94M +$9.17M +124,500 New
ST
122
Spot Trading
Illinois
$9.71M +$8.94M +121,348 New
Citigroup
123
Citigroup
New York
$9.18M +$8.47M +114,988 New
Edgewood Management
124
Edgewood Management
Connecticut
$8.84M +$8.13M +110,465 New
CBOA
125
Commonwealth Bank of Australia
Australia
$8.81M +$8.11M +110,084 New
3 4
5
6 7

VRTX Hedge Fund Activity: Q2 2013 in Review

376 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vertex Pharmaceuticals (VRTX) for Q2 2013, worth a combined $17.1B.

Buyers outnumbered sellers: 376 funds opened new VRTX positions and 0 closed out — a net gain of 376 holders — while 0 added to existing stakes and 0 trimmed.

  • 376 institutional investors held Vertex Pharmaceuticals (VRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.1B of Vertex Pharmaceuticals stock for Q2 2013.
  • 376 funds opened new Vertex Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +376 holders.

Based on aggregated 13F filings for Q2 2013.